BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CIS Webinars Reengage AMP Final Rule, Reflect on Bona Fide Service Fees


9/25/2013 8:19:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHILADELPHIA, Pa., Sept 24 , 2013 – Compliance Implementation Services (CIS), a leading life sciences consulting firm, toda y announced that it will host Governme nt Programs hot topic webinars on the AMP Final Rule and B ona F ide S ervice F ees this week .

Three years after the release of PPACA and a year and a half after the release of the Proposed Rule, it is now time for pharmaceutical manufacturers to reengage an d reevaluate their preparation for the Final Rule. With the tentative release date of January 2014 on the horizon, CIS will host the webinar entitled “ The CMS AMP Final Rule: It is Time to Re - engage ” on Wed nesday, September 25 featuring Chris Cobourn , Senior Vice President, Commercial Compliance, and Erika Scholl , Senio r Manager, Government Programs Consulting. They will discuss the various unique components in the Proposed Rule and their projected impact on statutory pricing calculations as well as overall business. For each component, they will look at the potential ou tcomes in the Final Rule, their likelihood of inclusion in the Final Rule, and what pharmaceutical manufacturers can do to plan and budget for the changes that will come. L earn more about this session in Cobourn's latest entry on the CIS blog .

The second webinar entitled “ Bona Fide Service Fees: Lessons Learned ” will be held on Thursday, September 26 featuring Rick Moore , Senior Manager, US Commercial Compliance, and Larri Short , Partner at Arent Fox LLC. They plan to go over the key takeaways from previous BFSF reviews and outline how compani es can embed policies and processes into their commercial and GP operations to ensure continued, current and effective analysis.

All webinars will be held from 2:00 - 3:15pm EST. For a complete list of upcoming webinars and to submit questions in advance, visit http://cis - partners.com/category/insight/webinars - insight/ .

About Compliance Implementation Services (CIS)

Compliance Implementation Services (CIS) is a consulting firm focus ed on helping life sciences clients proactively manage complex compliance requirements. We offer a broad portfolio of services and solutions that expand deep into the clinical, manufacturing and commercial disciplines and that align with our clients’ strat egic priorities and business operations. CIS continually provides leadership, global regulatory knowledge, industry experience and a problem - solving culture that responds to today’s compliance and commercial challenges. For more information, visit www.cis - partners.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES